Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study
Birth Defects Research Part A: Clinical and Molecular Teratology · 2014-10 · 100 (10) · 806-810
DOI: 10.1002/bdra.23319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research Part A: Clinical and Molecular Teratology, online erschienen am 08.10.2014. Verfasst von Denita Williams und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas; Huntingdon Li…. Hauptthemen laut MEDLINE: Disease Models, Animal, Pharmacokinetics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: FDA Medical Countermeasures Initiative.
Abstract (Originalsprache)
The U.S. Food and Drug Administration (FDA) and other federal agencies partner to ensure that medical countermeasures (e.g., drug therapies and vaccines) are available for public health emergencies (FDA, 2014). Despite continuing progress, providing medical countermeasures and treatment guidelines for certain populations (e.g., pregnant women) is challenging due to the lack of clinical and/or animal data. Thus, a workshop was convened to discuss animal models of pregnancy for the evaluation of disease progression and medical countermeasures. Birth Defects Research (Part A) 100:806–810, 2014. © 2014 Wiley Periodicals, Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas; Huntingdon Life Sciences, Inc., Somerset, New Jersey.
Förderung
- FDA Medical Countermeasures Initiative
Zitieren
APA
Williams, D., Basavarajappa, M. S., Rasmussen, S. A., Morris, S., Mattison, D., & Animal Models of Pregnancy Working Group (2014). Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study. Birth Defects Research Part A: Clinical and Molecular Teratology, 100(10), 806-810. https://doi.org/10.1002/bdra.23319
Vancouver
Williams D, Basavarajappa MS, Rasmussen SA, Morris S, Mattison D, Animal Models of Pregnancy Working Group. Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study. Birth Defects Research Part A: Clinical and Molecular Teratology. 2014;100(10):806-810. doi:10.1002/bdra.23319
BibTeX
@article{Williams2014,
author = {Williams, Denita and Basavarajappa, Mallikarjuna S and Rasmussen, Sonja A and Morris, Suzanne and Mattison, Donald and Animal Models of Pregnancy Working Group, Animal Models of Pregnancy Working Group},
title = {Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study},
journal = {Birth Defects Research Part A: Clinical and Molecular Teratology},
year = {2014},
volume = {100},
number = {10},
pages = {806--810},
doi = {10.1002/bdra.23319}
}
EUVIMED